IL6 and early-onset autosomal dominant Alzheimer disease: IL6 is a well know biomarker in diseases of the central nervous system (CNS), such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD) or Huntington’s disease (HD), due to its consistent upregulation whenever neuroinflammation is expected (37).